{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-039155","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.518500+00:00","generated_at":"2026-06-17T09:29:30.026866+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aprea Therapeutics reports FY2022 net loss of $112.7M; cash $28.8M, runway into Q3 2024","bullets":["Cash and cash equivalents $28.8M at Dec 31, 2022, down from $53.1M; with $5.5M public offering, runway into Q3 2024.","Q4 2022 net loss $2.4M ($0.92/share) vs $7.8M ($7.20/share) in Q4 2021; operating loss $2.7M vs $7.8M.","Full year 2022 net loss $112.7M ($67.99/share) including $76M acquired IPR&D, vs $37.1M in 2021.","R&D expenses fell to $0.5M in Q4 2022 from $4.5M as legacy trials wrapped; only one active trial vs six.","ATRN-119 Phase 1/2a enrolling; ATRN-1051 IND filing expected by end of 2023; AACR abstract selected."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-039155","json":"https://secwatch.observer/filing/0001104659-23-039155.json","markdown":"https://secwatch.observer/filing/0001104659-23-039155.md","text":"https://secwatch.observer/filing/0001104659-23-039155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923039155/0001104659-23-039155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923039155/tm2310933d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:29:30.026866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}